Entia Biosciences, Inc. 4
4 · Entia Biosciences, Inc. · Filed May 24, 2016
Insider Transaction Report
Form 4
JOHNSON CARL J
DirectorPresident, CEO
Transactions
- Purchase
Warrant
2016-05-20$0.13/sh+25,000$3,125→ 25,000 totalExercise: $0.13From: 2016-05-20Exp: 2019-05-20→ Common Stock (25,000 underlying) - Purchase
8% Conv Debenture
2016-05-20$0.10/sh→ 250,000 totalExercise: $0.10From: 2016-05-20Exp: 2019-05-20→ Common Stock (250,000 underlying)